Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

1,2,4-Amino-triazine derivatives as pyruvate dehydrogenase kinase inhibitors: Synthesis and pharmacological evaluation
Camilla Pecoraro, Michele De Franco, Daniela Carbone, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115134-115134
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Past, Present, and Future Perspectives on Computer-Aided Drug Design Methodologies
Davide Bassani, Stefano Moro
Molecules (2023) Vol. 28, Iss. 9, pp. 3906-3906
Open Access | Times Cited: 49
Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma
Daniela Carbone, Michele De Franco, Camilla Pecoraro, et al.
Marine Drugs (2023) Vol. 21, Iss. 5, pp. 288-288
Open Access | Times Cited: 24
Discovery of Atp Competitive Pdhk1/2 Dual Inhibitors
Guangtian Zou, Hong‐Tao Xu, Dong Ding, et al.
(2025)
Closed Access
1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivatives against Pancreatic Ductal Adenocarcinoma: Synthesis, Cytotoxic Activity, and Inhibition of CDK1
Daniela Carbone, Camilla Pecoraro, Giovanna Panzeca, et al.
Marine Drugs (2023) Vol. 21, Iss. 7, pp. 412-412
Open Access | Times Cited: 19
Recent advances in pyruvate dehydrogenase kinase inhibitors: Structures, inhibitory mechanisms and biological activities
Yiyang Li, Zhizhong Xie, Xiaoyong Lei, et al.
Bioorganic Chemistry (2024), pp. 107160-107160
Closed Access | Times Cited: 3
Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts
Tomas Koltai, Larry Fliegel
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 744-744
Open Access | Times Cited: 3
Recent advances on anticancer and antimicrobial activities of directly-fluorinated five-membered heterocycles and their benzo-fused systems
Ashraf A. Abbas, Thoraya A. Farghaly, Kamal M. Dawood
RSC Advances (2024) Vol. 14, Iss. 28, pp. 19752-19779
Open Access | Times Cited: 3
Azaindole derivatives as potential kinase inhibitors and their SARs elucidation
Guoqing Fang, Hongjuan Chen, Zhiyun Cheng, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115621-115621
Closed Access | Times Cited: 9
Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: Synthesis, mechanistic Insights and promising antitumor and safety profile
Daniela Carbone, Camilla Pecoraro, Fabio Scianò, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: synthesis, mechanistic insights and promising antitumor and safety profile
Camilla Pecoraro, Daniela Carbone, Fabio Scianò, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 10, pp. 1278-1294
Open Access | Times Cited: 2
Design, Synthesis, and Biological Evaluation of New Potential Unusual Modified Anticancer Immunomodulators for Possible Non-Teratogenic Quinazoline-Based Thalidomide Analogs
Reda R. Mabrouk, Abdallah E. Abdallah, Hazem A. Mahdy, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12416-12416
Open Access | Times Cited: 7
Unmasking the Warburg Effect: Unleashing the Power of Enzyme Inhibitors for Cancer Therapy
Eduardo Angulo-Elizari, Leire Gaviria-Soteras, Irati Zubiri, et al.
Drugs and Drug Candidates (2023) Vol. 2, Iss. 3, pp. 728-769
Open Access | Times Cited: 7
Targeting the pyruvate dehydrogenase complex/pyruvate dehydrogenase kinase (PDC/PDK) axis to discover potent PDK inhibitors through structure-based virtual screening and pharmacological evaluation
Lin‐Ling Gan, Ying Yang, Zizhen Liang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116008-116008
Closed Access | Times Cited: 7
Quinoxaline 1,4-Dioxides: Advances in Chemistry and Chemotherapeutic Drug Development
Galina I. Buravchenko, Andrey E. Shchekotikhin
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1174-1174
Open Access | Times Cited: 5
Biological activity and computational analysis of novel acrylonitrile derived benzazoles as potent antiproliferative agents for pancreatic adenocarcinoma with antioxidative properties
Anja Beč, Leentje Persoons, Dirk Daelemans, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107326-107326
Closed Access | Times Cited: 1
Reprogramming Energy Metabolism with Synthesized PDK Inhibitors Based on Dichloroacetate Derivatives and Targeted Delivery Systems for Enhanced Cancer Therapy
Wenyan She, Tingting Liu, Haimei Li, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14683-14699
Closed Access | Times Cited: 4
An Insight Into the Structure–Activity Relationship Studies of Anticancer Medicinal Attributes of 7-Azaindole Derivatives: A Review
Neha Sharma, Anurag Chaudhary, Monika Sachdeva
Future Medicinal Chemistry (2023) Vol. 15, Iss. 24, pp. 2309-2323
Closed Access | Times Cited: 4
Nortopsentins as Leads from Marine Organisms for Anticancer and Anti-Inflammatory Agent Development
Camilla Pecoraro, Francesca Terrana, Giovanna Panzeca, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6450-6450
Open Access | Times Cited: 4
Divergent Strategy for the Synthesis of Indolopyrazines Fused to Benzopyrimidinones and Benzimidazoles: Identification of Antiproliferative Molecules
Bilal O. Alkubaisi, Anusha Sebastian, Maximilian Bauer, et al.
ChemistrySelect (2023) Vol. 8, Iss. 46
Closed Access | Times Cited: 4
Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle Regulation
Robert Ferguson, Karen Aughton, A.G. Evans, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 3, pp. 2505-2520
Open Access | Times Cited: 2
Successful Outcome of a Patient with Concomitant Pancreatic and Renal Carcinoma Receiving Secoisolariciresinol Diglucoside Therapy Alone: A Case Report
Hao Wu, Xinghua Zhang, Liping Wang, et al.
International Medical Case Reports Journal (2024) Vol. Volume 17, pp. 167-175
Open Access
Design, synthesis, biological evaluation, and in silico studies of novel pyridopyridine derivatives as anticancer candidates targeting FMS kinase
Anusha Sebastian, Reinad R. Abu Rabah, Seyed–Omar Zaraei, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116557-116557
Closed Access
Design, Synthesis and Anti‐Cancer Evaluation of Quinoline‐1,2,4‐triazine Hybrids
Chang‐E Dong, Cong Qi, Rui‐Li, et al.
ChemistrySelect (2024) Vol. 9, Iss. 33
Closed Access
Comparative Analysis of Leptin and Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Plasma Expression in Pancreatic Cancer and Chronic Pancreatitis Patients
Gina Gheorghe, Carmen C. Diaconu, Cristina Mambet, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e37410-e37410
Open Access
5-NITRO-THIOPHENE-THIOSEMICARBAZONE DERIVATIVE INDUCES CELL DEATH, CELL CYCLE ARREST, AND PHOSPHO-KINASE SHUTDOWN IN PANCREATIC DUCTAL ADENOCARCINOMA CELLS
Valécia de Cássia Mendonça da Costa, Maria do Carmo Alves de Lima, Iranildo José da Cruz Filho, et al.
European Journal of Pharmacology (2024), pp. 176963-176963
Closed Access
Page 1 - Next Page

Scroll to top